
Mesoblast (MESO) has had the highest return between November 18, 1996 and November 18, 2026 by a US stock in the Biotechnology Industry, returning 11,909,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Mesoblast (MESO) | 11/18/1996 - 11/18/2026 | 11,909,900% |
Avita Medical (RCEL) | 11/18/1996 - 11/18/2026 | 3,942,400% |
MiMedx (MDXG) | 11/18/1996 - 11/18/2026 | 794,900% |
Insmed (INSM) | 11/18/1996 - 11/18/2026 | 232,901.91% |
Addex Therapeutics (ADXN) | 11/18/1996 - 11/18/2026 | 194,344.44% |
Immatics (IMTX) | 11/18/1996 - 11/18/2026 | 125,700% |
Lexaria Bioscience (LEXX) | 11/18/1996 - 11/18/2026 | 62,288.06% |
Jade Biosciences (JBIO) | 11/18/1996 - 11/18/2026 | 59,130.77% |
Altimmune (ALT) | 11/18/1996 - 11/18/2026 | 52,658.62% |
Evogene (EVGN) | 11/18/1996 - 11/18/2026 | 48,485.71% |
Gilead Sciences (GILD) | 11/18/1996 - 11/18/2026 | 34,233.53% |
Aurinia Pharmaceuticals (AUPH) | 11/18/1996 - 11/18/2026 | 24,658.84% |
MDxHealth (MDXH) | 11/18/1996 - 11/18/2026 | 16,455.56% |
AquaBounty Technologies (AQB) | 11/18/1996 - 11/18/2026 | 11,258.33% |
United Therapeutics (UTHR) | 11/18/1996 - 11/18/2026 | 8,553.33% |
Biogen (BIIB) | 11/18/1996 - 11/18/2026 | 8,119.66% |
Travere Therapeutics (TVTX) | 11/18/1996 - 11/18/2026 | 7,761.54% |
argenx NV ADR (ARGX) | 11/18/1996 - 11/18/2026 | 5,193.41% |
Regeneron Pharmaceuticals (REGN) | 11/18/1996 - 11/18/2026 | 4,922.31% |
Amgen (AMGN) | 11/18/1996 - 11/18/2026 | 4,581.4% |
Vertex Pharmaceuticals (VRTX) | 11/18/1996 - 11/18/2026 | 3,318.88% |
Krystal Biotech (KRYS) | 11/18/1996 - 11/18/2026 | 2,743.33% |
Alnylam Pharmaceuticals (ALNY) | 11/18/1996 - 11/18/2026 | 2,465.57% |
Halozyme Therapeutics (HALO) | 11/18/1996 - 11/18/2026 | 2,459.2% |
Cytokinetics (CYTK) | 11/18/1996 - 11/18/2026 | 1,965.75% |